IL6 and Fabry disease: Importantly, anti-IL-6 treatments are already in common clinical usage for the treatment of rheumatoid arthritis and have shown promising pain relief in a case report in FD; a clinical trial is ongoing (ClinicalTrials.gov identifier: NCT01791842).